(Q37927093)

25 August 2017

1 reference

title

Drug delivery strategies for poorly water-soluble drugs: the industrial perspective (English)

1 reference

25 August 2017

1 reference

3

Alfred Fahr

1 reference

25 August 2017

Peter van Hoogevest

1

1 reference

PubMed ID

21895540

25 August 2017

Xiangli Liu

series ordinal

2

1 reference

PubMed ID

21895540

25 August 2017

language of work or name

English

0 references

publication date

6 September 2011

1 reference

Expert Opinion on Drug Delivery

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

11

1 reference

25 August 2017

1481-1500

1 reference

Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery

25 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Drug delivery strategies for poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Pharmaceutical evaluation of early development candidates "the 100 mg-approach".

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Development and application of a high-throughput formulation screening strategy for oral administration in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Porous carriers for controlled/modulated drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Solubilizing excipients in oral and injectable formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Preclinical formulations for discovery and toxicology: physicochemical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Developing early formulations: practice and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Liposomal drug delivery: recent patents and emerging opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Patents on nanoparticulate drug delivery systems--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Cyclodextrins as pharmaceutical solubilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Phospholipids and lipid-based formulations in oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Cyclodextrin-based pharmaceutics: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Pharmaceutical Applications of Solid Dispersion Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Review: physical chemistry of solid dispersions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Self-assembly of cyclodextrins: the effect of the guest molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Practical aspects of lyophilization using non-aqueous co-solvent systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.614228

10.1517/17425247.2011.614228

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21895540